Blood Loss and Preeclampsia

Launched by UNIVERSITY OF ZURICH · Mar 1, 2021

Keywords

ClinConnect Summary

This clinical trial, titled "Blood Loss and Preeclampsia," is studying how blood loss affects women who have preeclampsia during their pregnancy. Preeclampsia is a condition that can cause high blood pressure and other complications, often requiring a caesarean section for delivery. Researchers will use mathematical formulas to better understand the blood loss in these patients, which could help improve care for women experiencing this condition.

To participate in the trial, women aged 65 to 74 who are scheduled for an elective or urgent caesarean section and can provide written consent may be eligible. However, women who are having an emergency caesarean section, have certain blood disorders, or are taking specific medications like anticoagulants or aspirin will not be included. If you join this study, you can expect to be closely monitored during your procedure to gather important information about blood loss and its impact on your health. This research aims to enhance our understanding of preeclampsia and improve treatment options for future patients.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Elective or urgent caesarean section
• • Written informed consent
• Exclusion Criteria:
• • Emergency caesarean section
• • Familial coagulation disorder
• • Hematological disorders that affect the platelet count, e.g. myelodysplastic syndrome (MDS)
• • Taking anticoagulants
• • Taking aspirin in the last 14 days
• • Use of NSARs in the last 24 hours